A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Haleon PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 937,100 shares of HLN stock, worth $9.79 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
937,100
Holding current value
$9.79 Million
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$8.01 - $8.64 $7.51 Million - $8.1 Million
937,100 New
937,100 $7.74 Million
Q3 2023

Nov 14, 2023

BUY
$7.85 - $8.94 $210,380 - $239,592
26,800 New
26,800 $223,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $48.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.